Search research articles
Contact Us
Filters
Showing results (31-40 of 40) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 40 results.
Psychopharmacology
|
January 1, 1993
Selective serotonin re-uptake inhibitors decrease schedule-induced polydipsia in rats: a potential model for obsessive compulsive disorder
A Woods, C Smith, M Szewczak, et al.
Environmental Monitoring and Assessment
|
November 22, 2013
In situ nitrogen enrichment experiments in two Idaho (U.S.A.) streams
C Y Manuel-Faler, G W Minshall, R W Dunn, et al.
Journal of Medicinal Chemistry
|
March 1, 1991
Synthesis and biological evaluation of a series of substituted N-alkoxyimides and -amides as potential atypical antipsychotic agents
N J Hrib, J G Jurcak, F P Huger, et al.
Drug Design and Discovery
|
February 1, 1992
3-substituted-1,2-benzisoxazoles: novel antipsychotic agents
L Davis, R C Effland, J T Klein, et al.
Psychopharmacology
|
July 1, 1995
Antipsychotic agents antagonize non-competitive N-methyl-D-aspartate antagonist-induced behaviors
R Corbett, F Camacho, A T Woods, et al.
Pharmacology, Biochemistry, and Behavior
|
May 1, 1993
Effects of atypical antipsychotic agents on social behavior in rodents
R Corbett, H Hartman, L L Kerman, et al.
Progress in Clinical and Biological Research
|
January 1, 1990
Preclinical anxiolytic profiles of 7189 and 8319, novel non-competitive NMDA antagonists
R W Dunn, R Corbett, L L Martin, et al.
Journal of Medicinal Chemistry
|
June 1, 1985
Synthesis and neuroleptic activity of 3-(1-substituted-4-piperidinyl)-1,2-benzisoxazoles
J T Strupczewski, R C Allen, B A Gardner, et al.
European Journal of Pharmacology
|
April 22, 1992
Stereoselective R-(+) enantiomer of HA-966 displays anxiolytic effects in rodents
R W Dunn, D M Flanagan, L L Martin, et al.
Journal of Medicinal Chemistry
|
July 10, 1992
3-[4-[1-(6-Fluorobenzo[b]thiophen-3-yl)-4-piperazinyl]butyl]- 2,5,5-trimethyl-4-thiazolidinone: a new atypical antipsychotic agent for the treatment of schizophrenia
N J Hrib, J G Jurcak, D E Bregna, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 40) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 40 results.
Psychopharmacology
|
January 1, 1993
Selective serotonin re-uptake inhibitors decrease schedule-induced polydipsia in rats: a potential model for obsessive compulsive disorder
A Woods, C Smith, M Szewczak, et al.
Environmental Monitoring and Assessment
|
November 22, 2013
In situ nitrogen enrichment experiments in two Idaho (U.S.A.) streams
C Y Manuel-Faler, G W Minshall, R W Dunn, et al.
Journal of Medicinal Chemistry
|
March 1, 1991
Synthesis and biological evaluation of a series of substituted N-alkoxyimides and -amides as potential atypical antipsychotic agents
N J Hrib, J G Jurcak, F P Huger, et al.
Drug Design and Discovery
|
February 1, 1992
3-substituted-1,2-benzisoxazoles: novel antipsychotic agents
L Davis, R C Effland, J T Klein, et al.
Psychopharmacology
|
July 1, 1995
Antipsychotic agents antagonize non-competitive N-methyl-D-aspartate antagonist-induced behaviors
R Corbett, F Camacho, A T Woods, et al.
Pharmacology, Biochemistry, and Behavior
|
May 1, 1993
Effects of atypical antipsychotic agents on social behavior in rodents
R Corbett, H Hartman, L L Kerman, et al.
Progress in Clinical and Biological Research
|
January 1, 1990
Preclinical anxiolytic profiles of 7189 and 8319, novel non-competitive NMDA antagonists
R W Dunn, R Corbett, L L Martin, et al.
Journal of Medicinal Chemistry
|
June 1, 1985
Synthesis and neuroleptic activity of 3-(1-substituted-4-piperidinyl)-1,2-benzisoxazoles
J T Strupczewski, R C Allen, B A Gardner, et al.
European Journal of Pharmacology
|
April 22, 1992
Stereoselective R-(+) enantiomer of HA-966 displays anxiolytic effects in rodents
R W Dunn, D M Flanagan, L L Martin, et al.
Journal of Medicinal Chemistry
|
July 10, 1992
3-[4-[1-(6-Fluorobenzo[b]thiophen-3-yl)-4-piperazinyl]butyl]- 2,5,5-trimethyl-4-thiazolidinone: a new atypical antipsychotic agent for the treatment of schizophrenia
N J Hrib, J G Jurcak, D E Bregna, et al.
Page
of 4